Daily aspirin cuts venous thromboembolism recurrence A daily dose of 100mg aspirin cuts venous thromboembolism recurrence by up to 42% over two years, without significantly increasing bleeding risk.…
Fenofibrate works in women as well as men Research finds cardiovascular event reductions with fenofibrate are consistently similar in women and men, challenging previous results that suggested a gender disparity.…
Latest trials do not support link between bisphosphonate use and reduced breast cancer risk Randomised controlled trials fail to confirm association between osteoporosis treatments and decreased breast cancer risk in postmenopausal women.…
MRSA screening guidance updated in light of NOW studyNew Department of Health guidance recommends that only two types of patients will be screened for MRSA.…
Acute management and prevention of gout Ways to treat this painful condition that affects almost 900,000 people in the UK and how lifestyle changes can prevent further attacks.…
Scientists develop gold nanoparticles to deliver cisplatin University of Cambridge scientists have developed gold nanoparticles containing cisplatin as part of a twofold attack on glioblastoma.…
‘Nasal brushing’ technique shows promise for diagnosis of Creutzfeldt–Jakob disease A simple, minimally invasive diagnostic technique could help identify patients infected with Creutzfeldt–Jakob disease, new research suggests.…
Researchers question value of NHS Health Checks delivered by GPsNHS health checks may not be any better than usual GP practice care in increasing the prevalence of the diseases they were designed to target.…
Medicines supply chain ‘overwhelmed’ by Ebola crisis Pharmacists working in West Africa have spoken about the overwhelming scale of the challenges they have faced in Liberia in the battle against the Ebola virus.…
GSK’s malaria vaccine shows 45% efficacy in children An ongoing phase III study in Africa indicates that vaccination of children and young infants with RTS,S/AS01 prevented many cases of clinical and severe malaria.…